Danaher Announces Fourth Quarter 2025 Estimated Financial Performance

Details

The company expects mid-single digit year-over-year revenue growth and non-GAAP core revenue growth toward the high-end of its previously announced low-single digit percentage guidance. Full-year 2025 non-GAAP adjusted diluted net earnings per common share are anticipated to be toward the high-end of the $7.70 to $7.80 guidance range. CEO Rainer M. Blair commented on the solid finish to 2025 and the company's position for long-term value creation. Danaher's presentation slides and press release can be found on the 'Investors' section of its website.

Items reported

About Danaher Corporation

Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.